Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2019-12-03T12:52:41Z
dc.date.available 2019-12-03T12:52:41Z
dc.date.issued 2015
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/86566
dc.description.abstract Type 2 diabetes mellitus is a metabolic disease characterized by persistent hyperglycemia. High blood sugar can produce long-term complications such as cardiovascular and renal disorders, retinopathy, and poor blood flow. Its development can be prevented or delayed in people with impaired glucose tolerance by implementing lifestyle changes or the use of therapeutic agents. Some of these drugs have been obtained from plants or have a microbial origin, such as galegine isolated from Galega officinalis, which has a great similarity to the antidiabetic drug metformin. Picnogenol, acarbose, miglitol, and voglibose are other antidiabetic products of natural origin. This review compiles the principal articles on medicinal plants used for treating diabetes and its comorbidities, as well as mechanisms of natural products as antidiabetic agents. Inhibition of α-glucosidase and α-amylase, effects on glucose uptake and glucose transporters, modification of mechanisms mediated by the peroxisome proliferator-activated receptor, inhibition of protein tyrosine phosphatase 1B activity, modification of gene expression, and activities of hormones involved in glucose homeostasis such as adiponectin, resistin, and incretin, and reduction of oxidative stress are some of the mechanisms in which natural products are involved. We also review the most relevant clinical trials performed with medicinal plants and natural products such as aloe, banaba, bitter melon, caper, cinnamon, cocoa, coffee, fenugreek, garlic, guava, gymnema, nettle, sage, soybean, green and black tea, turmeric, walnut, and yerba mate. Compounds of high interest as potential antidiabetics are: fukugetin, palmatine, berberine, honokiol, amorfrutins, trigonelline, gymnemic acids, gurmarin, and phlorizin. en
dc.format.extent 975-994 es
dc.language en es
dc.subject antidiabetic es
dc.subject clinical trials es
dc.subject diabetes es
dc.subject medicinal plants es
dc.title Natural Products for the Treatment of Type 2 Diabetes Mellitus en
dc.type Articulo es
sedici.identifier.other doi:10.1055/s-0035-1546131 es
sedici.identifier.other eid:2-s2.0-84939652973 es
sedici.identifier.issn 0032-0943 es
sedici.creator.person Ríos, José Luis es
sedici.creator.person Francini, Flavio es
sedici.creator.person Schinella, Guillermo Raúl es
sedici.subject.materias Ciencias Médicas es
sedici.description.fulltext true es
mods.originInfo.place Facultad de Ciencias Médicas es
mods.originInfo.place Centro de Endocrinología Experimental y Aplicada es
sedici.subtype Revision es
sedici.rights.license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Planta Medica es
sedici.relation.journalVolumeAndIssue vol. 81, no. 12-13 es
sedici.rights.sherpa * Color: blue * Pre-print del autor: cannot * Post-print del autor: can * Versión de editor/PDF:can * Condiciones: >>Author's post-print or Publisher's version/PDF on author's personal website immediately >>Author's post-print in Institutional Repository and PubMed Central after 12 months embargo >>Publisher's version/PDF can be used on author's personal website only >>Publisher copyright and source must be acknowledged >>Link to Publisher version (www.thieme-connect.com) must be included if article has been published online >>Publisher last contacted on 31/03/2015 * Link a Sherpa: http://sherpa.ac.uk/romeo/issn/0032-0943/es/


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)